<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31432465</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1678-4405</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>50</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]</Title>
          <ISOAbbreviation>Braz J Microbiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.</ArticleTitle>
        <Pagination>
          <StartPage>943</StartPage>
          <EndPage>952</EndPage>
          <MedlinePgn>943-952</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s42770-019-00129-8</ELocationID>
        <Abstract>
          <AbstractText>Brazilian data for maternal GBS colonization shows different prevalence rates. This conflicting data may be related to the absence of an official recommendation from the Federal Brazilian Health Authorities describing guidelines and protocols to perform GBS screening in pregnant women, in both public and private clinics. In the present review, we evaluated published reports addressing the prevalence of GBS in different regions of the country, methods used, and, when available, information regarding antibiotic resistance and serological typing of clinical isolates. According to this review, GBS prevalence in pregnant women in Brazil ranged from 4.2 to 28.4%, in the last 10 years. Serotype Ia was the most prevalent. The highest antibiotic resistance rates were found for tetarcycline, although its use to treat GBS infections is not common. Our results also show high resistance rates to clindamycin and erythromycin, which are commonly used as an alternative to penicillin in GBS infecctions. The increased antibiotic resistance, variations in serotype distribution, and high GBS prevalences need to be further investigated. Based on the present situation, recommendations regarding GBS surveillance in the country were raised and may improve our strategies for preventing neonatal infections.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>do Nascimento</LastName>
            <ForeName>Cilicia S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dos Santos</LastName>
            <ForeName>Nayara F B</ForeName>
            <Initials>NFB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Biomedical Science Institute, University of São Paulo (USP), São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferreira</LastName>
            <ForeName>Rita C C</ForeName>
            <Initials>RCC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Biomedical Science Institute, University of São Paulo (USP), São Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taddei</LastName>
            <ForeName>Carla R</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil. crtaddei@usp.br.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Arts, Sciences and Humanities, University of São Paulo (USP), São Paulo, Brazil. crtaddei@usp.br.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Braz J Microbiol</MedlineTA>
        <NlmUniqueID>101095924</NlmUniqueID>
        <ISSNLinking>1517-8382</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013290" MajorTopicYN="N">Streptococcal Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013292" MajorTopicYN="N">Streptococcus agalactiae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">Pregnancy</Keyword>
        <Keyword MajorTopicYN="N">Sepsis</Keyword>
        <Keyword MajorTopicYN="N">Streptococcus agalactiae</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31432465</ArticleId>
        <ArticleId IdType="pmc">PMC6863207</ArticleId>
        <ArticleId IdType="doi">10.1007/s42770-019-00129-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s42770-019-00129-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S, Heath PT. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–556. doi: 10.1016/S0140-6736(11)61651-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(11)61651-6</ArticleId>
            <ArticleId IdType="pubmed">22226047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen GH, Randis TM, Desai PV, Sapra KJ, Ma B, Gajer P, Humphrys MS, Ravel J, Gelber SE, Ratner AJ. Group B Streptococcus and the vaginal microbiota. J Infect Dis. 2017;216(6):744–751. doi: 10.1093/infdis/jix395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jix395</ArticleId>
            <ArticleId IdType="pmc">PMC5853324</ArticleId>
            <ArticleId IdType="pubmed">28934437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doran KS, Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol. 2004;54(1):23–31. doi: 10.1111/j.1365-2958.2004.04266.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2004.04266.x</ArticleId>
            <ArticleId IdType="pubmed">15458402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO (2017) Group B Streptococcus infection causes an estimated 150,000 preventable stillbirths and infant deaths every year. Immunization, Vaccines Biol</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Verani JR, McGee L, Schrag SJ. Prevention of perinatal Group B Streptococcal disease. Revised Guidelines from CDC, 2010. Morb Mortal Wkly. 2010;59(RR-10):1–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21088663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohlsson A, Shah VS (2016) Intrapartum antibiotics for known maternal Group B streptococcal colonization (Review) Intrapartum antibiotics for known maternal Group B streptococcal colonization. (6):2014–2016. 10.1002/14651858.CD007467.pub4.Copyright</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24915629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taminato M, Fram D, Torloni MR, Belasco AGS, Saconato H, Barbosa DA. Screening for group b streptococcus in pregnant women: a systematic review and meta-analysis. Rev Lat Am Enfermagem. 2011;19(6):1470–1478. doi: 10.1590/S0104-11692011000600026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0104-11692011000600026</ArticleId>
            <ArticleId IdType="pubmed">22249684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards MS, Nizet V, Baker CJ.  Infectious diseases of the fetus and newborn. 6. Philadelphia, PA: Elsevier Saunders; 2011. Group B streptococcal infections; pp. 419–469.</Citation>
        </Reference>
        <Reference>
          <Citation>Vornhagen J, Adams KMA, Rajagopal L. Perinatal group B streptococcal infections: virulence factors, immunity, and prevention strategies. Trends Microbiol. 2017;25(11):919–931. doi: 10.1016/j.tim.2017.05.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2017.05.013</ArticleId>
            <ArticleId IdType="pmc">PMC5650539</ArticleId>
            <ArticleId IdType="pubmed">28633864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns G, Plumb J. GBS public awareness, advocacy, and prevention-what’s working, what’s not and why we need a maternal GBS vaccine. Vaccine. 2013;31(S4):D58–D65. doi: 10.1016/j.vaccine.2013.02.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2013.02.039</ArticleId>
            <ArticleId IdType="pubmed">23973348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Royal College of Obstetricians and Gynaecologists  Prevention of early-onset neonatal Group B Streptococcal disease: Green-top Guideline No. 36. BJOG An Int J Obstet Gynaecol. 2017;124(12):e280–e305. doi: 10.1111/1471-0528.14821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1471-0528.14821</ArticleId>
            <ArticleId IdType="pubmed">28901693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agência Nacional de Vigilância Sanitária  Microbiologia clínica para o controle de infecção relacionada à assistência à saúde. Agência Nac Vigilância Sanitária - Anvisa. 2013;6:1–154.</Citation>
        </Reference>
        <Reference>
          <Citation>Lang S, Palmer M. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem. 2003;278(40):38167–38173. doi: 10.1074/jbc.M303544200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M303544200</ArticleId>
            <ArticleId IdType="pubmed">12835325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa HdPF (2011) Prevenção Da Doença Perinatal Pelo Estreptococo Do Grupo B 1–18</Citation>
        </Reference>
        <Reference>
          <Citation>Júnior AdOF (2014) Protocolo de Assistência Materno Infantil Do Estado Do Rio Grande Do Norte</Citation>
        </Reference>
        <Reference>
          <Citation>Kahhale S (2012) Protocolos de Obstetrícia : Descrição, Diagnóstico, Tratamento 1–4. 10.15713/ins.mmj.3</Citation>
        </Reference>
        <Reference>
          <Citation>Secretaria de Estado da Saúde (2017) Protocolo de Atenção Ao Pré-Natal: Risco Habitual:1–4. 10.15713/ins.mmj.3</Citation>
        </Reference>
        <Reference>
          <Citation>Secretaria Municipal de Saúde do Rio de Janeiro (SMS-Rio) (2016) Atenção ao Pré-Natal Rotinas para gestantes de baixo risco. Coleção Guia Ref Rápida. http://www.rio.rj.gov.br/dlstatic/10112/6552790/4176323/GuiaPrenatal_reunido.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Brasil. Ministério Da Saúde (2012) Atenção Ao Pré-Natal de Baixo Risco. Brasilia: Editora do Ministério da Saúde. http://bvsms.saude.gov.br/bvs/publicacoes/cadernos_atencao_basica_32_prenatal.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Costa AL d R, Lamy Filho F, Chein MB d C, Brito LMO, Lamy ZC, Andrade KL. Prevalência de colonização por estreptococos do grupo B em gestantes atendidas em maternidade pública da região Nordeste do Brasil. Rev Bras Ginecol Obs. 2008;30(6):274–280. doi: 10.1590/S0100-72032008000600002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-72032008000600002</ArticleId>
            <ArticleId IdType="pubmed">19142504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linhares JJ, Neto PGC, Vasconcelos JLM, et al.  Prevalência de colonização por Streptococcus agalactiae em gestantes atendidas em maternidade do Ceará, no Brasil, correlacionando com os resultados perinatais. Rev Bras Ginecol e Obs. 2011;33(12):395–400. doi: 10.1590/S0100-72032011001200004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-72032011001200004</ArticleId>
            <ArticleId IdType="pubmed">22282027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ventura MSM, Rodrigues JLN, Feitosa FE d L, Junior CA d A, Almeida PC. Colonização por Streptococcus do Grupo B em Gestantes com Trabalho de Parto Prematuro e/ou Ruptura Prematura das Membranas. Arq Med. 2011;25(2):61–66.</Citation>
        </Reference>
        <Reference>
          <Citation>Oliveira MV, Teles MF, Viana TA (2013) PREVALÊNCIA E FATORES DE RISCO ASSOCIADOS À COLONIZAÇÃO POR Streptococcusagalactiae EM GESTANTES ATENDIDAS NO HOSPITAL MUNICIPAL ESAÚ MATOS EM VITÓRIA DA CONQUISTA – BA. C&amp;D-Revista Eletrônica da Fainor,. 6(1):172–184. http://srv02.fainor.com.br/revista/index.php/memorias/article/view/197%5Cnsrv02.fainor.com.br/revista237/index.php/memorias/article/.../197/146?</Citation>
        </Reference>
        <Reference>
          <Citation>Nomura ML, Passini Júnior R, Oliveira UM, Calil R. Colonização materna e neonatal por estreptococo do grupo B em situações de ruptura pré-termo de membranas e no trabalho de parto prematuro. Rev Bras Ginecol e Obs. 2009;31(8):397–403. doi: 10.1590/S0100-72032009000800005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-72032009000800005</ArticleId>
            <ArticleId IdType="pubmed">19838588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rezende C, Azeredo A, Silveira DG, Malta RCG, de Castro V d CO, Miziara RC. PESQUISA DE Streptococcus agalactiae NA SECREÇÃO VAGINAL E ANAL DE GESTANTES DE UM MUNICÍPIO DO NOROESTE PAULISTA. Rev Uniara. 2010;13(2):194–201.</Citation>
        </Reference>
        <Reference>
          <Citation>Martins BL, Jacob T, De Oliveira C. Prevalência de Streptococcus agalactiae em secreção vaginal de gestantes atendidas em um laboratório de análises clínicas do interior do estado de são Paulo. SALUSVITA. 2017;36(3):695–707.</Citation>
        </Reference>
        <Reference>
          <Citation>Marconi C, Rocchetti TT, Rall VLM, De Carvalho LR, Borges VTM, Da Silva MG. Detection of Streptococcus agalactiae colonization in pregnant women by using combined swab cultures: cross-sectional prevalence study. Sao Paulo Med J. 2010;128(2):60–62. doi: 10.1590/S1516-31802010000200003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1516-31802010000200003</ArticleId>
            <ArticleId IdType="pubmed">20676570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rocchetti TT, Marconi C, Rall VLM, Borges VTM, Corrente JE, Da Silva MG. Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora. Arch Gynecol Obstet. 2010;283(4):717–721. doi: 10.1007/s00404-010-1439-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-010-1439-8</ArticleId>
            <ArticleId IdType="pubmed">20349243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lajos GJ, Passini Junior R, Nomura ML, Amaral E, Pereira BG, Milanez H, Parpinelli MÂ. Colonização bacteriana do canal cervical em gestantes com trabalho de parto prematuro ou ruptura prematura de membranas. Rev Bras Ginecol e Obs. 2008;30(8):393–399. doi: 10.1590/S0100-72032008000800004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-72032008000800004</ArticleId>
            <ArticleId IdType="pubmed">19142522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higashi AB, da Silva IR, Goldman RE. Prevalence of Streptococcus of Group B in pregnant women and the relation with neonatal infection. Rev Enferm e Atenção à Saúde. 2016;5(1):24–36.</Citation>
        </Reference>
        <Reference>
          <Citation>Função JM, Narchi NZ. PESQUISA DO ESTREPTOCOCO DO GRUPO B EM GESTANTES DA ZONA LESTE DE SÃO PAULO. Rev da Esc Enferm da USP. 2013;47(1):22–29. doi: 10.1590/S0080-62342013000100003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0080-62342013000100003</ArticleId>
            <ArticleId IdType="pubmed">23515799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Botelho ACN, Oliveira JG, Damasco AP, Santos KTB, Ferreira AFM, Rocha GT, Marinho PS, Bornia RBG, Pinto TCA, Américo MA, Fracalanzza SEL, Teixeira LM. Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years. PLoS One. 2018;13(5):e0196925. doi: 10.1371/journal.pone.0196925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0196925</ArticleId>
            <ArticleId IdType="pmc">PMC5947911</ArticleId>
            <ArticleId IdType="pubmed">29750801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellano-Filho DS, da Silva VL, Nascimento TC, Vieira M d T, Diniz CG. Detection of group B Streptococcus in Brazilian pregnant women and antimicrobial susceptibility patterns. Braz J Microbiol. 2010;41(4):1047–1055. doi: 10.1590/S1517-83822010000400024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1517-83822010000400024</ArticleId>
            <ArticleId IdType="pmc">PMC3769761</ArticleId>
            <ArticleId IdType="pubmed">24031585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atkins KL, Atkinson RM, Shanks A, Parvin CA, Dunne WM, Gross G. Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method. Obstet Gynecol. 2006;108(3 Pt 1):488–491. doi: 10.1097/01.AOG.0000228961.42272.31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.AOG.0000228961.42272.31</ArticleId>
            <ArticleId IdType="pubmed">16946205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastos AN, Bastos RV, Dias VC, Bastos LQ d A, Souza RC d, Bastos VQ d A. Streptococcus agalactiae em gestantes : incidência em laboratório clínico de Juiz de Fora ( MG ) - 2007 a 2009. HU Rev. 2012;38(2):45–50.</Citation>
        </Reference>
        <Reference>
          <Citation>Barbosa NG, de Brito DVD, dos Reis H, et al.  Colonização Materna Por Estreptococos Do Grupo B : Prevalência E Suscetibilidade Aos Antimicrobianos. Rev Pesqui em Saúde. 2016;17(1):13–16.</Citation>
        </Reference>
        <Reference>
          <Citation>de Melo SCCS, Balandis Costa A, Teixeira F, et al.  Prevalence of Streptococcus agalactiae colonization in pregnant women from the 18th Health Region of Paraná State. Rev Inst Med Trop Sao Paulo. 2018;60(2):2–7. doi: 10.1590/S1678-9946201860002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1678-9946201860002</ArticleId>
            <ArticleId IdType="pmc">PMC5813665</ArticleId>
            <ArticleId IdType="pubmed">29451592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Melo SCCS, Santos NC d S, Oliveira M d, et al.  Antimicrobial susceptibility of Streptococcus agalactiae isolated from pregnant women. Rev Inst Med Trop Sao Paulo. 2016;58(1):83. doi: 10.1590/S1678-9946201658083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1678-9946201658083</ArticleId>
            <ArticleId IdType="pmc">PMC5096637</ArticleId>
            <ArticleId IdType="pubmed">27828624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiss FS, Rossato J d S, Graudenz MS, Gutierrez LLP. Prevalência da colonização por Streptococcus agalactiae em uma amostra de mulheres grávidas e não grávidas de Porto Alegre, estado do Rio Grande do Sul. Sci Med (Porto Alegre) 2013;23(3):169–174.</Citation>
        </Reference>
        <Reference>
          <Citation>Senger FR, Alves IA, Pellegrini D d CP, Prestes DC, Souza EF d, Corte ED. Prevalência da colonização por Streptococcus agalactiae em gestantes atendidas na rede pública de saúde de Santo Ângelo/RS. Rev Epidemiol e Control Infecção. 2015;6(1):1–5. doi: 10.17058/reci.v6i1.6272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17058/reci.v6i1.6272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veit AR, Roehrs MCSM, Mayer LE, Santos SO, Martini R, Tizotti MK, Kempfer CB, Martins VR, Fronza L, Cunha MDC, Colpo PR, Konopka CK, Horner R. Colonization prevalence and susceptibility of Streptococcus agalactiae in pregnant women at HUSM. Saúde (Santa Maria) 2011;36(1):9–14. doi: 10.5902/223658342391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5902/223658342391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapatai G, Patel D, Efstratiou A, Chalker VJ. Comparison of molecular serotyping approaches of Streptococcus agalactiae from genomic sequences. BMC Genomics. 2017;18(1):1–11. doi: 10.1186/s12864-017-3820-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-017-3820-5</ArticleId>
            <ArticleId IdType="pmc">PMC5455115</ArticleId>
            <ArticleId IdType="pubmed">28571573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80(2):212–214. doi: 10.1016/j.mimet.2009.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mimet.2009.11.010</ArticleId>
            <ArticleId IdType="pubmed">19958797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol. 2007;45(9):2929–2936. doi: 10.1128/JCM.00117-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00117-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045254</ArticleId>
            <ArticleId IdType="pubmed">17634306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis. 2009;49(1):85–92. doi: 10.1086/599369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/599369</ArticleId>
            <ArticleId IdType="pubmed">19480572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: state of the art. Ther Adv Vaccines. 2015;3(3):76–90. doi: 10.1177/2051013615579869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2051013615579869</ArticleId>
            <ArticleId IdType="pmc">PMC4530403</ArticleId>
            <ArticleId IdType="pubmed">26288735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phares CR, Lynfield R, Farley MM, et al.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;2008(17):2056–2065. doi: 10.1016/S0084-3873(08)79076-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0084-3873(08)79076-X</ArticleId>
            <ArticleId IdType="pubmed">18460666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tettelin H, Masignani V, Cieslewicz MJ, Eisen JA, Peterson S, Wessels MR, Paulsen IT, Nelson KE, Margarit I, Read TD, Madoff LC, Wolf AM, Beanan MJ, Brinkac LM, Daugherty SC, DeBoy RT, Durkin AS, Kolonay JF, Madupu R, Lewis MR, Radune D, Fedorova NB, Scanlan D, Khouri H, Mulligan S, Carty HA, Cline RT, van Aken SE, Gill J, Scarselli M, Mora M, Iacobini ET, Brettoni C, Galli G, Mariani M, Vegni F, Maione D, Rinaudo D, Rappuoli R, Telford JL, Kasper DL, Grandi G, Fraser CM. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A. 2002;99(19):12391–12396. doi: 10.1073/pnas.182380799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.182380799</ArticleId>
            <ArticleId IdType="pmc">PMC129455</ArticleId>
            <ArticleId IdType="pubmed">12200547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497–513. doi: 10.1128/CMR.11.3.497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.11.3.497</ArticleId>
            <ArticleId IdType="pmc">PMC88893</ArticleId>
            <ArticleId IdType="pubmed">9665980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Doare K, Faal A, Jaiteh M, et al.  Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort. Vaccine. 2017;35(22):2970–2978. doi: 10.1016/j.vaccine.2017.04.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.04.013</ArticleId>
            <ArticleId IdType="pmc">PMC5432431</ArticleId>
            <ArticleId IdType="pubmed">28449969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simoes JA, Alves VMN, Fracalanzza SEL, Camargo RPS, Mathias L, Milanez HMBP, Brolazo EM. Phenotypical characteristics of group B streptococcus in parturients. Braz J Infect Dis. 2007;11(2):261–266. doi: 10.1590/S1413-86702007000200019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1413-86702007000200019</ArticleId>
            <ArticleId IdType="pubmed">17625774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soares GCT, Alviano DS, da Silva Santos G, Alviano CS, Mattos-Guaraldi AL, Nagao PE. Prevalence of Group B Streptococcus serotypes III and V in pregnant women of Rio de Janeiro, Brazil. Braz J Microbiol. 2013;44(3):869–872. doi: 10.1590/S1517-83822013000300032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1517-83822013000300032</ArticleId>
            <ArticleId IdType="pmc">PMC3910203</ArticleId>
            <ArticleId IdType="pubmed">24516454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmeiro JK, Dalla-Costa LM, Fracalanzza SEL, Botelho ACN, da Silva Nogueira K, Scheffer MC, de Almeida Torres RSL, de Carvalho NS, Cogo LL, Madeira HMF. Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil. J Clin Microbiol. 2010;48(12):4397–4403. doi: 10.1128/JCM.00419-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00419-10</ArticleId>
            <ArticleId IdType="pmc">PMC3008495</ArticleId>
            <ArticleId IdType="pubmed">20881175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrade PD, Russo J d S, Gouveia JB, et al.  Molecular characterization of group B Streptococcus serotypes by multiplex polymerase chain reaction. Med Express. 2017;4(4):6–8. doi: 10.5935/MedicalExpress.2017.04.06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5935/MedicalExpress.2017.04.06</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother. 2012;67(4):849–856. doi: 10.1093/jac/dkr546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkr546</ArticleId>
            <ArticleId IdType="pubmed">22210756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Easmon CSF, Hastings MJG, Clare AJ, et al.  Nosocomial transmission of group B streptococci. Br Med J (Clin Res Ed) 1981;283(6289):459–461. doi: 10.1136/bmj.283.6289.459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.283.6289.459</ArticleId>
            <ArticleId IdType="pmc">PMC1506284</ArticleId>
            <ArticleId IdType="pubmed">6790015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutra VG, Alves VMN, Olendzki AN, Dias CAG, de Bastos AFA, Santos GO, de Amorin ELT, Sousa MÂB, Santos R, Ribeiro PCS, Fontes CF, Andrey M, Magalhães K, Araujo AA, Paffadore LF, Marconi C, Murta EFC, Fernandes Jr PC, Raddi MSG, Marinho PS, Bornia RBG, Palmeiro JK, Dalla-Costa LM, Pinto TCA, Botelho ACN, Teixeira LM, Fracalanzza SEL. Streptococcus agalactie in Brazil: serotype distribution, virulence determinants and antimicrobiol suscetibility. BMC Infect Dis. 2014;14(1):323–330. doi: 10.1186/1471-2334-14-323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-14-323</ArticleId>
            <ArticleId IdType="pmc">PMC4061772</ArticleId>
            <ArticleId IdType="pubmed">24919844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto TCA, Costa NS, Vianna Souza AR, da Silva LG, Corrêa ABA, Fernandes FG, Oliveira ICM, de Mattos MC, Rosado AS, Benchetrit LC. Distribution of serotypes and evaluation of antimicrobial susceptibility among human and bovine Streptococcus agalactiae strains isolated in Brazil between 1980 and 2006. Braz J Infect Dis. 2013;17(2):131–136. doi: 10.1016/j.bjid.2012.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjid.2012.09.006</ArticleId>
            <ArticleId IdType="pubmed">23453948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwatra Gaurav, Cunnington Marianne C, Merrall Elizabeth, Adrian Peter V, Ip Margaret, Klugman Keith P, Tam Wing Hung, Madhi Shabir A. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2016;16(9):1076–1084. doi: 10.1016/S1473-3099(16)30055-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(16)30055-X</ArticleId>
            <ArticleId IdType="pubmed">27236858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barbosa NG, dos Reis H, Mantese OC, Mussi-Pinhata MM, Abdallah VOS, Gontijo Filho PP. Early-onset neonatal sepsis by Group B Streptococcus in a Brazilian public hospital. Braz J Infect Dis. 2016;20(6):647–648. doi: 10.1016/j.bjid.2016.07.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjid.2016.07.013</ArticleId>
            <ArticleId IdType="pubmed">27565421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evangelista MLB, de Mello Freitas FT. Group B streptococcus neonatal infection in an intensive care unit in Brazil: high fatality and missed opportunities for antibiotic prophylaxis. Braz J Infect Dis. 2015;19(1):98–99. doi: 10.1016/j.bjid.2014.06.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjid.2014.06.007</ArticleId>
            <ArticleId IdType="pubmed">25179512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (2010) Prevention of perinatal Group B Streptococcal disease. Morb Mortal Wkly. 10.1097/01.EDE.0000032431.83648.8D</Citation>
        </Reference>
        <Reference>
          <Citation>Costa NDVL, De Carvalho M, Pone SM, Saint CG. Gestantes colonizadas pelo Streptococcus do grupo B e seus recémnascidos: Análise crítica da conduta adotada no Instituto Fernandes Figueira, Fundação Oswaldo Cruz. Rev Paul Pediatr. 2010;28(2):155–161. doi: 10.1590/S0103-05822010000200005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0103-05822010000200005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>da Silva FA, Vidal CF d L, Araújo EC d. Validation of the content of the prevention protocol for early sepsis caused by Streptococcus agalactiaein newborns. Rev Lat Am Enfermagem. 2015;23(4):635–641. doi: 10.1590/0104-1169.0179.2598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/0104-1169.0179.2598</ArticleId>
            <ArticleId IdType="pmc">PMC4623726</ArticleId>
            <ArticleId IdType="pubmed">26444165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva JM, Stein AT, Schünemann HJ, Bordin R, Kuchenbecker R, de Lourdes Drachler M. Academic detailing and adherence to guidelines for Group B streptococci prenatal screening: a randomized controlled trial. BMC Pregnancy Childbirth. 2013;13(68):1–5. doi: 10.1186/1471-2393-13-68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2393-13-68</ArticleId>
            <ArticleId IdType="pmc">PMC3610286</ArticleId>
            <ArticleId IdType="pubmed">23510061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Mello DS, Tsunechiro MA, Mendelski CA, Pierre SA, Silva AR, Padoveze MC. Group B Streptococcus: compliance with the information in prenatal card records and knowledge of pregnant women. Am J Infect Control. 2015;43(4):400–401. doi: 10.1016/j.ajic.2014.12.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajic.2014.12.026</ArticleId>
            <ArticleId IdType="pubmed">25702842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(S4):D52–D57. doi: 10.1016/j.vaccine.2013.02.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2013.02.029</ArticleId>
            <ArticleId IdType="pubmed">23973347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teatero S, Ferrieri P, Martin I, Demczuk W, McGeer A, Fittipaldi N. Serotype distribution, population structure, and antimicrobial resistance of Group B Streptococcus strains recovered from colonized pregnant women. Burnham C-AD, ed. J Clin Microbiol. 2017;55(2):412–422. doi: 10.1128/JCM.01615-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01615-16</ArticleId>
            <ArticleId IdType="pmc">PMC5277510</ArticleId>
            <ArticleId IdType="pubmed">27852675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Da Cunha V, Davies MR, Douarre PE, et al.  Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun. 2014;5:1–12. doi: 10.1038/ncomms5544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms5544</ArticleId>
            <ArticleId IdType="pmc">PMC4538795</ArticleId>
            <ArticleId IdType="pubmed">25088811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amundson NR, Flores AE, Hillier SL, Baker CJ, Ferrieri P. DNA macrorestriction analysis of nontypeable group b streptococcal isolates: clonal evolution of nontypeable and type v isolates. J Clin Microbiol. 2005;43(2):572–576. doi: 10.1128/JCM.43.2.572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.2.572</ArticleId>
            <ArticleId IdType="pmc">PMC548113</ArticleId>
            <ArticleId IdType="pubmed">15695647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States. Atlanta, Georgia; 2013. http://www.cdc.gov/drugresistance/threat-report-2013/index.html</Citation>
        </Reference>
        <Reference>
          <Citation>Glezen WP, Alpers M. Maternal immunization. Clin Infect Dis. 1999;28(2):219–224. doi: 10.1086/515122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/515122</ArticleId>
            <ArticleId IdType="pubmed">10064230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolukaoto JY, Monyama CM, Chukwu MO, Lekala SM, Nchabeleng M, Maloba MRB, Mavenyengwa RT, Lebelo SL, Monokoane ST, Tshepuwane C, Moyo SR. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res Notes. 2015;8(1):6–12. doi: 10.1186/s13104-015-1328-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13104-015-1328-0</ArticleId>
            <ArticleId IdType="pmc">PMC4544793</ArticleId>
            <ArticleId IdType="pubmed">26289147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corrrêa AB d A, da Silva LG, Pinto T d CA, et al.  The genetic diversity and phenotypic characterization of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2011;106(8):1002–1006. doi: 10.1590/S0074-02762011000800017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0074-02762011000800017</ArticleId>
            <ArticleId IdType="pubmed">22241124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura PAM, Schuab RBB, Neves FPG, Pereira CFA, de Paula GR, Barros RR. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Mem Inst Oswaldo Cruz. 2011;106(2):119–122. doi: 10.1590/S0074-02762011000200001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0074-02762011000200001</ArticleId>
            <ArticleId IdType="pubmed">21537668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahesh S, Hensler ME, Van Sorge NM, et al.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother. 2008;52(8):2915–2918. doi: 10.1128/AAC.00461-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00461-08</ArticleId>
            <ArticleId IdType="pmc">PMC2493126</ArticleId>
            <ArticleId IdType="pubmed">18541727</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
